NEW ORLEANS, La. — A 15-year-old Louisiana teenager is making medical history after becoming the first person in the state to receive a groundbreaking gene therapy treatment that has functionally cured his sickle cell disease.
Phillip Mullin, of Alexandria, Louisiana, received a treatment known as Lyfgenia at Manning Family Children’s Hospital in New Orleans. The stem cell gene therapy has given the teenager new hope after a lifetime of serious health complications.
Mullin has spent much of his childhood battling sickle cell disease, enduring more than 100 hospital stays.
According to the Centers for Disease Control and Prevention, sickle cell disease is an inherited blood disorder that causes red blood cells to become abnormally shaped. These cells can block blood flow, leading to severe pain, infections, strokes and other potentially life-threatening complications.
For Mullin and his family, the treatment represents an opportunity to move beyond years of uncertainty and medical emergencies.
His mother, Shataka Figgins, reflected on the emotional toll of watching her son struggle with the disease.
“I think I’ll be unpacking every fear, every negative emotion that I had, every time I thought my baby wasn’t going to be here with me,” Figgins said. “I will remember every sleepless night and every moment I wondered how much more his body could take, but I will also see the young man who made it through.”
During a ceremony Friday at Manning Family Children’s Hospital celebrating the successful treatment, Mullin delivered an emotional speech about perseverance, sacrifice and the support of his family.
“Sacrifices are necessary,” Mullin said. “You can’t gain anything without first giving something in return, although if you can endure that pain and walk away from it, you find that you now have a heart strong enough to overcome any obstacle.”
He also paid tribute to his sister, Paige, whom he described as his superhero and one of his greatest sources of strength throughout his medical journey.
New Orleans Saints legend Archie Manning, one of the hospital’s namesakes, attended the ceremony and praised Mullin for his courage and determination.
“What a… just a… wonderful young man,” Manning said. “His mind is really something, so it’s a miracle, and it’s great. I’m glad to be here to be part of it.”
Lyfgenia works by modifying a patient’s own blood-forming stem cells to help the body produce healthier red blood cells and reduce the severe complications associated with sickle cell disease. While the treatment can provide lasting relief, patients still require long-term medical monitoring.
The breakthrough could offer hope to other families affected by sickle cell disease, including those across Louisiana and Mississippi, where the condition remains a significant health concern.
Mullin hopes his experience will encourage more people living with the disease to explore available treatment options.
He also has plans to turn his personal experience into a career helping others. The teenager wants to return to school and eventually become a hematologist-oncologist, a physician who specializes in treating blood disorders and cancer.
“I want to be a doctor that can relate to somebody… relate to a sickle cell patient and actually know what they’re going through,” Mullin said.
For now, however, Mullin is looking forward to enjoying the simpler parts of being a teenager.
After years of hospital visits and medical treatments, he says he is ready to return home, sleep in his own bed and spend time building Legos with his younger sister.
Comments